This report aims to provide a comprehensive study of the global market for Heparin API.
Report Highlights:

(1) Global Heparin API market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Heparin API market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China Heparin API market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global Heparin API segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Heparin API segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Heparin API, capacity, production and trends.

(7) Heparin API industry supply chain, upstream, midstream and downstream analysis.

According to Latest Research, the global market for Heparin API should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Heparin API market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Heparin API market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Heparin Sodium segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Venous Thrombosis has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Heparin API include Sanofi, Pfizer, Rovi Pharma, Merz Pharmaceuticals, Alfasigma, SPL, Bioiberica, China Resources Sanjiu Pharmaceutical and Kivipharm, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

By Product Type, the market is primarily segmented into:

Heparin Sodium

Enoxaparin

Nadroparin

Dalteparin

Others

By Applications, the market is segmented into:

Venous Thrombosis

Acute Coronary Syndrome

Atrial Fibrillation

Cardiovascular Surgery

Hemodialysis

Others

Key Players Driving the Market:

Sanofi

Pfizer

Rovi Pharma

Merz Pharmaceuticals

Alfasigma

SPL

Bioiberica

China Resources Sanjiu Pharmaceutical

Kivipharm

Baiyu Pharmaceutical

Jida Pharmaceutical

SL Pharmaceutical

Jiuyuan Gene Engineering

Qianhong Biopharma

Harbin Pharmaceutical Group Bioengineering

New Time Pharmaceutical

Dongcheng Biochemicals

Hepalink Pharmaceutical

1 Market Overview

1.1 Heparin API Definition

1.2 Global Heparin API Market Size and Forecast

1.2.1 By Revenue, Global Heparin API Market Size, 2018-2029

1.2.2 By Sales Volume, Global Heparin API Market Size, 2018-2029

1.2.3 Global Heparin API Price Trend, 2018-2029

1.3 China Heparin API Market Size and Forecast

1.3.1 By Revenue, China Heparin API Market Size, 2018-2029

1.3.2 By Sales Volume, China Heparin API Market Size, 2018-2029

1.3.3 China Heparin API Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Heparin API Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China Heparin API Share in Global Market, 2018-2029

1.4.3 Heparin API Market Size: China VS Global, 2018-2029

1.5 Heparin API Market Dynamics

1.5.1 Heparin API Market Drivers

1.5.2 Heparin API Market Restraints

1.5.3 Heparin API Industry Trends

1.5.4 Heparin API Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Heparin API Revenue by Company, 2018-2023

2.2 Global Heparin API Sales Volume by Company, 2018-2023

2.3 Global Heparin API Price by Company, 2018-2023

2.4 Global Heparin API Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Heparin API Concentration Ratio

2.6 Global Heparin API Mergers & Acquisitions, Expansion Plans

2.7 Global Heparin API Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Heparin API Revenue by Company, 2018-2023

3.2 China Heparin API Sales Volume by Company, 2018-2023

3.3 China Heparin API Heparin API Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Heparin API Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, Heparin API Domestic VS Export

3.6 China Market, Heparin API Import & Export

3.6.1 China Market, Heparin API Import & Export, 2018-2029

3.6.2 China Heparin API Import & Export Trends

3.6.3 Main Sources of China Heparin API Import

3.6.4 Export Destination of China Heparin API

4 Heparin API Production by Region

4.1 Global Heparin API Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of Heparin API Manufacturers

4.3 Global Major Manufacturers, Heparin API Capacity Expansion and Future Plans

4.4 Global Heparin API Capacity by Region

4.5 Global Heparin API Production by Region

4.5.1 Global Heparin API Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global Heparin API Production by Region, 2018-2023

4.5.3 Global Heparin API Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Heparin API Industry Chain

5.2 Heparin API Upstream Analysis

5.2.1 Heparin API Core Raw Materials

5.2.2 Main Manufacturers of Heparin API Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Heparin API Production Mode

5.6 Heparin API Procurement Model

5.7 Heparin API Industry Sales Model and Sales Channels

5.7.1 Heparin API Sales Model

5.7.2 Heparin API Typical Distributors

6 Sights by Type

6.1 Heparin API Classification

6.1.1 Heparin Sodium

6.1.2 Enoxaparin

6.1.3 Nadroparin

6.1.4 Dalteparin

6.1.5 Others

6.2 By Type, Global Heparin API Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Heparin API Revenue, 2018-2029

6.4 By Type, Global Heparin API Sales Volume, 2018-2029

6.5 By Type, Global Heparin API Price, 2018-2029

7 Sights by Application

7.1 Heparin API Segment by Application

7.1.1 Venous Thrombosis

7.1.2 Acute Coronary Syndrome

7.1.3 Atrial Fibrillation

7.1.4 Cardiovascular Surgery

7.1.5 Hemodialysis

7.1.6 Others

7.2 By Application, Global Heparin API Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Heparin API Revenue, 2018-2029

7.4 By Application, Global Heparin API Sales Volume, 2018-2029

7.5 By Application, Global Heparin API Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Heparin API Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global Heparin API Revenue, 2018-2029

8.3 By Region, Global Heparin API Sales Volume, 2018-2029

8.4 North America

8.4.1 North America Heparin API Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America Heparin API Market Size Market Share

8.5 Europe

8.5.1 Europe Heparin API Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Heparin API Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Heparin API Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Heparin API Market Size Market Share

8.7 South America

8.7.1 South America Heparin API Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Heparin API Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Heparin API Market Size & CAGR，2018 VS 2022 VS 2029

9.2 By Country, Global Heparin API Revenue, 2018-2029

9.3 By Country, Global Heparin API Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. Heparin API Market Size, 2018-2029

9.4.2 By Company, U.S. Heparin API Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Heparin API Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. Heparin API Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Heparin API Market Size, 2018-2029

9.5.2 By Company, Europe Heparin API Sales Volume Market Share, 2022

9.5.3 By Type, Europe Heparin API Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe Heparin API Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China Heparin API Market Size, 2018-2029

9.6.2 By Company, China Heparin API Sales Volume Market Share, 2022

9.6.3 By Type, China Heparin API Market Size, Share, 2022 VS 2029

9.6.4 By Application, China Heparin API Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Heparin API Market Size, 2018-2029

9.7.2 By Company, Japan Heparin API Sales Volume Market Share, 2022

9.7.3 By Type, Japan Heparin API Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan Heparin API Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Heparin API Market Size, 2018-2029

9.8.2 By Company, South Korea Heparin API Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Heparin API Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea Heparin API Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Heparin API Market Size, 2018-2029

9.9.2 By Company, Southeast Asia Heparin API Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Heparin API Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia Heparin API Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India Heparin API Market Size, 2018-2029

9.10.2 By Company, India Heparin API Sales Volume Market Share, 2022

9.10.3 By Type, India Heparin API Market Size, Share, 2022 VS 2029

9.10.4 By Application, India Heparin API Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia Heparin API Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia Heparin API Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Heparin API Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia Heparin API Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Sanofi

10.1.1 Sanofi Company Information, Head Office, Market Area and Industry Position

10.1.2 Sanofi Heparin API Models, Specifications and Application

10.1.3 Sanofi Heparin API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Sanofi Company Profile and Main Business

10.1.5 Sanofi Recent Developments

10.2 Pfizer

10.2.1 Pfizer Company Information, Head Office, Market Area and Industry Position

10.2.2 Pfizer Heparin API Models, Specifications and Application

10.2.3 Pfizer Heparin API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Pfizer Company Profile and Main Business

10.2.5 Pfizer Recent Developments

10.3 Rovi Pharma

10.3.1 Rovi Pharma Company Information, Head Office, Market Area and Industry Position

10.3.2 Rovi Pharma Heparin API Models, Specifications and Application

10.3.3 Rovi Pharma Heparin API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 Rovi Pharma Company Profile and Main Business

10.3.5 Rovi Pharma Recent Developments

10.4 Merz Pharmaceuticals

10.4.1 Merz Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

10.4.2 Merz Pharmaceuticals Heparin API Models, Specifications and Application

10.4.3 Merz Pharmaceuticals Heparin API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Merz Pharmaceuticals Company Profile and Main Business

10.4.5 Merz Pharmaceuticals Recent Developments

10.5 Alfasigma

10.5.1 Alfasigma Company Information, Head Office, Market Area and Industry Position

10.5.2 Alfasigma Heparin API Models, Specifications and Application

10.5.3 Alfasigma Heparin API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Alfasigma Company Profile and Main Business

10.5.5 Alfasigma Recent Developments

10.6 SPL

10.6.1 SPL Company Information, Head Office, Market Area and Industry Position

10.6.2 SPL Heparin API Models, Specifications and Application

10.6.3 SPL Heparin API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 SPL Company Profile and Main Business

10.6.5 SPL Recent Developments

10.7 Bioiberica

10.7.1 Bioiberica Company Information, Head Office, Market Area and Industry Position

10.7.2 Bioiberica Heparin API Models, Specifications and Application

10.7.3 Bioiberica Heparin API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 Bioiberica Company Profile and Main Business

10.7.5 Bioiberica Recent Developments

10.8 China Resources Sanjiu Pharmaceutical

10.8.1 China Resources Sanjiu Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.8.2 China Resources Sanjiu Pharmaceutical Heparin API Models, Specifications and Application

10.8.3 China Resources Sanjiu Pharmaceutical Heparin API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 China Resources Sanjiu Pharmaceutical Company Profile and Main Business

10.8.5 China Resources Sanjiu Pharmaceutical Recent Developments

10.9 Kivipharm

10.9.1 Kivipharm Company Information, Head Office, Market Area and Industry Position

10.9.2 Kivipharm Heparin API Models, Specifications and Application

10.9.3 Kivipharm Heparin API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Kivipharm Company Profile and Main Business

10.9.5 Kivipharm Recent Developments

10.10 Baiyu Pharmaceutical

10.10.1 Baiyu Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.10.2 Baiyu Pharmaceutical Heparin API Models, Specifications and Application

10.10.3 Baiyu Pharmaceutical Heparin API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.10.4 Baiyu Pharmaceutical Company Profile and Main Business

10.10.5 Baiyu Pharmaceutical Recent Developments

10.11 Jida Pharmaceutical

10.11.1 Jida Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.11.2 Jida Pharmaceutical Heparin API Models, Specifications and Application

10.11.3 Jida Pharmaceutical Heparin API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.11.4 Jida Pharmaceutical Company Profile and Main Business

10.11.5 Jida Pharmaceutical Recent Developments

10.12 SL Pharmaceutical

10.12.1 SL Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.12.2 SL Pharmaceutical Heparin API Models, Specifications and Application

10.12.3 SL Pharmaceutical Heparin API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.12.4 SL Pharmaceutical Company Profile and Main Business

10.12.5 SL Pharmaceutical Recent Developments

10.13 Jiuyuan Gene Engineering

10.13.1 Jiuyuan Gene Engineering Company Information, Head Office, Market Area and Industry Position

10.13.2 Jiuyuan Gene Engineering Heparin API Models, Specifications and Application

10.13.3 Jiuyuan Gene Engineering Heparin API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.13.4 Jiuyuan Gene Engineering Company Profile and Main Business

10.13.5 Jiuyuan Gene Engineering Recent Developments

10.14 Qianhong Biopharma

10.14.1 Qianhong Biopharma Company Information, Head Office, Market Area and Industry Position

10.14.2 Qianhong Biopharma Heparin API Models, Specifications and Application

10.14.3 Qianhong Biopharma Heparin API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.14.4 Qianhong Biopharma Company Profile and Main Business

10.14.5 Qianhong Biopharma Recent Developments

10.15 Harbin Pharmaceutical Group Bioengineering

10.15.1 Harbin Pharmaceutical Group Bioengineering Company Information, Head Office, Market Area and Industry Position

10.15.2 Harbin Pharmaceutical Group Bioengineering Heparin API Models, Specifications and Application

10.15.3 Harbin Pharmaceutical Group Bioengineering Heparin API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.15.4 Harbin Pharmaceutical Group Bioengineering Company Profile and Main Business

10.15.5 Harbin Pharmaceutical Group Bioengineering Recent Developments

10.16 New Time Pharmaceutical

10.16.1 New Time Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.16.2 New Time Pharmaceutical Heparin API Models, Specifications and Application

10.16.3 New Time Pharmaceutical Heparin API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.16.4 New Time Pharmaceutical Company Profile and Main Business

10.16.5 New Time Pharmaceutical Recent Developments

10.17 Dongcheng Biochemicals

10.17.1 Dongcheng Biochemicals Company Information, Head Office, Market Area and Industry Position

10.17.2 Dongcheng Biochemicals Heparin API Models, Specifications and Application

10.17.3 Dongcheng Biochemicals Heparin API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.17.4 Dongcheng Biochemicals Company Profile and Main Business

10.17.5 Dongcheng Biochemicals Recent Developments

10.18 Hepalink Pharmaceutical

10.18.1 Hepalink Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.18.2 Hepalink Pharmaceutical Heparin API Models, Specifications and Application

10.18.3 Hepalink Pharmaceutical Heparin API Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.18.4 Hepalink Pharmaceutical Company Profile and Main Business

10.18.5 Hepalink Pharmaceutical Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Heparin API Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Heparin API Market Restraints

Table 3. Heparin API Market Trends

Table 4. Heparin API Industry Policy

Table 5. Global Heparin API Revenue by Company, 2018-2023, US$ million

Table 6. Global Heparin API Revenue Market Share by Company, 2018-2023

Table 7. Global Heparin API Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Heparin API Sales Volume Market Share by Company, 2018-2023

Table 9. Global Heparin API Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Heparin API Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Heparin API Mergers & Acquisitions, Expansion Plans

Table 12. Global Heparin API Manufacturers Product Type

Table 13. China Heparin API Revenue by Company, 2018-2023, US$ million

Table 14. China Heparin API Revenue Market Share by Company, 2018-2023

Table 15. China Heparin API Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Heparin API Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Heparin API Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Heparin API Import & Export Trends

Table 19. Main Sources of China Heparin API Import

Table 20. Export Destination of China Heparin API

Table 21. Global Headquarters and Manufacturing Base of Heparin API Manufacturers

Table 22. Global Major Manufacturers, Heparin API Capacity Expansion and Future Plans

Table 23. Global Heparin API Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Heparin API Production by Region, 2018-2023, (K Units)

Table 25. Global Heparin API Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Heparin API Upstream (Raw Materials)

Table 27. Global Heparin API Typical Customers

Table 28. Heparin API Typical Distributors

Table 29. By Type, Global Heparin API Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Heparin API Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Heparin API Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Heparin API Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Heparin API Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Heparin API Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Heparin API Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Heparin API Revenue Market Share, 2018-2029

Table 37. By Country, Global Heparin API Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Heparin API Sales Volume Market Share, 2018-2029

Table 39. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 40. Sanofi Heparin API Models, Specifications and Application

Table 41. Sanofi Heparin API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Sanofi Company Profile and Main Business

Table 43. Sanofi Recent Developments

Table 44. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 45. Pfizer Heparin API Models, Specifications and Application

Table 46. Pfizer Heparin API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Pfizer Company Profile and Main Business

Table 48. Pfizer Recent Developments

Table 49. Rovi Pharma Company Information, Head Office, Market Area and Industry Position

Table 50. Rovi Pharma Heparin API Models, Specifications and Application

Table 51. Rovi Pharma Heparin API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Rovi Pharma Company Profile and Main Business

Table 53. Rovi Pharma Recent Developments

Table 54. Merz Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 55. Merz Pharmaceuticals Heparin API Models, Specifications and Application

Table 56. Merz Pharmaceuticals Heparin API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Merz Pharmaceuticals Company Profile and Main Business

Table 58. Merz Pharmaceuticals Recent Developments

Table 59. Alfasigma Company Information, Head Office, Market Area and Industry Position

Table 60. Alfasigma Heparin API Models, Specifications and Application

Table 61. Alfasigma Heparin API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Alfasigma Company Profile and Main Business

Table 63. Alfasigma Recent Developments

Table 64. SPL Company Information, Head Office, Market Area and Industry Position

Table 65. SPL Heparin API Models, Specifications and Application

Table 66. SPL Heparin API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. SPL Company Profile and Main Business

Table 68. SPL Recent Developments

Table 69. Bioiberica Company Information, Head Office, Market Area and Industry Position

Table 70. Bioiberica Heparin API Models, Specifications and Application

Table 71. Bioiberica Heparin API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Bioiberica Company Profile and Main Business

Table 73. Bioiberica Recent Developments

Table 74. China Resources Sanjiu Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 75. China Resources Sanjiu Pharmaceutical Heparin API Models, Specifications and Application

Table 76. China Resources Sanjiu Pharmaceutical Heparin API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. China Resources Sanjiu Pharmaceutical Company Profile and Main Business

Table 78. China Resources Sanjiu Pharmaceutical Recent Developments

Table 79. Kivipharm Company Information, Head Office, Market Area and Industry Position

Table 80. Kivipharm Heparin API Models, Specifications and Application

Table 81. Kivipharm Heparin API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Kivipharm Company Profile and Main Business

Table 83. Kivipharm Recent Developments

Table 84. Baiyu Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 85. Baiyu Pharmaceutical Heparin API Models, Specifications and Application

Table 86. Baiyu Pharmaceutical Heparin API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Baiyu Pharmaceutical Company Profile and Main Business

Table 88. Baiyu Pharmaceutical Recent Developments

Table 89. Jida Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 90. Jida Pharmaceutical Heparin API Models, Specifications and Application

Table 91. Jida Pharmaceutical Heparin API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. Jida Pharmaceutical Company Profile and Main Business

Table 93. Jida Pharmaceutical Recent Developments

Table 94. SL Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 95. SL Pharmaceutical Heparin API Models, Specifications and Application

Table 96. SL Pharmaceutical Heparin API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 97. SL Pharmaceutical Company Profile and Main Business

Table 98. SL Pharmaceutical Recent Developments

Table 99. Jiuyuan Gene Engineering Company Information, Head Office, Market Area and Industry Position

Table 100. Jiuyuan Gene Engineering Heparin API Models, Specifications and Application

Table 101. Jiuyuan Gene Engineering Heparin API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 102. Jiuyuan Gene Engineering Company Profile and Main Business

Table 103. Jiuyuan Gene Engineering Recent Developments

Table 104. Qianhong Biopharma Company Information, Head Office, Market Area and Industry Position

Table 105. Qianhong Biopharma Heparin API Models, Specifications and Application

Table 106. Qianhong Biopharma Heparin API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 107. Qianhong Biopharma Company Profile and Main Business

Table 108. Qianhong Biopharma Recent Developments

Table 109. Harbin Pharmaceutical Group Bioengineering Company Information, Head Office, Market Area and Industry Position

Table 110. Harbin Pharmaceutical Group Bioengineering Heparin API Models, Specifications and Application

Table 111. Harbin Pharmaceutical Group Bioengineering Heparin API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 112. Harbin Pharmaceutical Group Bioengineering Company Profile and Main Business

Table 113. Harbin Pharmaceutical Group Bioengineering Recent Developments

Table 114. New Time Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 115. New Time Pharmaceutical Heparin API Models, Specifications and Application

Table 116. New Time Pharmaceutical Heparin API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 117. New Time Pharmaceutical Company Profile and Main Business

Table 118. New Time Pharmaceutical Recent Developments

Table 119. Dongcheng Biochemicals Company Information, Head Office, Market Area and Industry Position

Table 120. Dongcheng Biochemicals Heparin API Models, Specifications and Application

Table 121. Dongcheng Biochemicals Heparin API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 122. Dongcheng Biochemicals Company Profile and Main Business

Table 123. Dongcheng Biochemicals Recent Developments

Table 124. Hepalink Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 125. Hepalink Pharmaceutical Heparin API Models, Specifications and Application

Table 126. Hepalink Pharmaceutical Heparin API Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 127. Hepalink Pharmaceutical Company Profile and Main Business

Table 128. Hepalink Pharmaceutical Recent Developments

List of Figure

Figure 1. Heparin API Picture

Figure 2. By Revenue, Global Heparin API Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Heparin API Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global Heparin API Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Heparin API Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Heparin API Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China Heparin API Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Heparin API Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Heparin API Share of Global Market, 2018-2029

Figure 10. Global Heparin API Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Heparin API Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Heparin API Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Heparin API Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Heparin API Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Heparin API Domestic VS Export, 2022

Figure 16. Global Heparin API Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Heparin API Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Heparin API Production Market Share & Forecast by Region, 2018-2029

Figure 19. Heparin API Industry Chain

Figure 20. Heparin API Procurement Model

Figure 21. Heparin API Sales Model

Figure 22. Heparin API Sales Channels, Direct Sales and Distribution

Figure 23. Heparin Sodium

Figure 24. Enoxaparin

Figure 25. Nadroparin

Figure 26. Dalteparin

Figure 27. Others

Figure 28. By Type, Global Heparin API Revenue, 2018-2029, US$ Million

Figure 29. By Type, Global Heparin API Revenue Market Share, 2018-2029

Figure 30. By Type, Global Heparin API Sales Volume, 2018-2029, (K Units)

Figure 31. By Type, Global Heparin API Sales Volume Market Share, 2018-2029

Figure 32. By Type, Global Heparin API Price, 2018-2029, (US$/Unit)

Figure 33. Venous Thrombosis

Figure 34. Acute Coronary Syndrome

Figure 35. Atrial Fibrillation

Figure 36. Cardiovascular Surgery

Figure 37. Hemodialysis

Figure 38. Others

Figure 39. By Application, Global Heparin API Revenue, 2018-2029, US$ Million

Figure 40. By Application, Global Heparin API Revenue Market Share, 2018-2029

Figure 41. By Application, Global Heparin API Sales Volume, 2018-2029, (K Units)

Figure 42. By Application, Global Heparin API Sales Volume Market Share, 2018-2029

Figure 43. By Application, Global Heparin API Price, 2018-2029, (US$/Unit)

Figure 44. By Region, Global Heparin API Revenue Market Share, 2018-2029

Figure 45. By Region, Global Heparin API Sales Volume Market Share, 2018-2029

Figure 46. North America Heparin API Revenue & Forecasts, 2018-2029, US$ Million

Figure 47. By Country, North America Heparin API Revenue Market Share, 2022

Figure 48. Europe Heparin API Revenue & Forecasts, 2018-2029, US$ Million

Figure 49. By Country, Europe Heparin API Revenue Market Share, 2022

Figure 50. Asia Pacific Heparin API Revenue & Forecasts, 2018-2029, US$ Million

Figure 51. By Country/Region, Asia Pacific Heparin API Revenue Market Share, 2022

Figure 52. South America Heparin API Revenue & Forecasts, 2018-2029, US$ Million

Figure 53. By Country, South America Heparin API Revenue Market Share, 2022

Figure 54. Middle East & Africa Heparin API Revenue & Forecasts, 2018-2029, US$ Million

Figure 55. U.S. Heparin API Sales Volume, 2018-2029, (K Units)

Figure 56. By Company, U.S. Heparin API Market Share, 2022

Figure 57. By Type, U.S. Heparin API Sales Volume Market Share, 2022 VS 2029

Figure 58. By Application, U.S. Heparin API Sales Volume Market Share, 2022 VS 2029

Figure 59. Europe Heparin API Sales Volume, 2018-2029, (K Units)

Figure 60. By Company, Europe Heparin API Market Share, 2022

Figure 61. By Type, Europe Heparin API Sales Volume Market Share, 2022 VS 2029

Figure 62. By Application, Europe Heparin API Sales Volume Market Share, 2022 VS 2029

Figure 63. China Heparin API Sales Volume, 2018-2029, (K Units)

Figure 64. By Company, China Heparin API Market Share, 2022

Figure 65. By Type, China Heparin API Sales Volume Market Share, 2022 VS 2029

Figure 66. By Application, China Heparin API Sales Volume Market Share, 2022 VS 2029

Figure 67. Japan Heparin API Sales Volume, 2018-2029, (K Units)

Figure 68. By Company, Japan Heparin API Market Share, 2022

Figure 69. By Type, Japan Heparin API Sales Volume Market Share, 2022 VS 2029

Figure 70. By Application, Japan Heparin API Sales Volume Market Share, 2022 VS 2029

Figure 71. South Korea Heparin API Sales Volume, 2018-2029, (K Units)

Figure 72. By Company, South Korea Heparin API Market Share, 2022

Figure 73. By Type, South Korea Heparin API Sales Volume Market Share, 2022 VS 2029

Figure 74. By Application, South Korea Heparin API Sales Volume Market Share, 2022 VS 2029

Figure 75. Southeast Asia Heparin API Sales Volume, 2018-2029, (K Units)

Figure 76. By Company, Southeast Asia Heparin API Market Share, 2022

Figure 77. By Type, Southeast Asia Heparin API Sales Volume Market Share, 2022 VS 2029

Figure 78. By Application, Southeast Asia Heparin API Sales Volume Market Share, 2022 VS 2029

Figure 79. India Heparin API Sales Volume, 2018-2029, (K Units)

Figure 80. By Company, India Heparin API Market Share, 2022

Figure 81. By Type, India Heparin API Sales Volume Market Share, 2022 VS 2029

Figure 82. By Application, India Heparin API Sales Volume Market Share, 2022 VS 2029

Figure 83. Middle East & Asia Heparin API Sales Volume, 2018-2029, (K Units)

Figure 84. By Company, Middle East & Asia Heparin API Market Share, 2022

Figure 85. By Type, Middle East & Asia Heparin API Sales Volume Market Share, 2022 VS 2029

Figure 86. By Application, Middle East & Asia Heparin API Sales Volume Market Share, 2022 VS 2029

Figure 87. Research Methodology

Figure 88. Breakdown of Primary Interviews

Figure 89. Bottom-up Approaches

Figure 90. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)